linkedin
BROUGHT TO YOU BY
Exclusive Access, Inclusive Growth

WELCOME TO ET PRIME

BROUGTH TO YOU BY
Exclusive Access, Inclusive Growth

Get access to free reads

Start Your Trial Start Your membership

Get 15-day free trial to all of ET Prime

Start Your Trial Start Your membership
Not a member
Already a member?
Not a member

Your membership

RENEW

Deals

1
Deals

ZEE promoters are battle bruised, not down and out

With the Chandra family now holding just 5% stake in ZEE, many think the company may be eyed for hostile takeovers. But Subhash Chandra’s decision to step down as chairman neither means his exit from the company, nor his family losing control of ZEE. The promoters enjoy complete support of Invesco Oppenheimer, now the largest shareholder.

headset AUDIO SUMMARY . 01:46
Deals

How Biosense founders spent 12 years on innovation to create a sustainable enterprise before exiting

In November 2019, Tulip Diagnostics bought a 99% stake in Biosense for an undisclosed amount. Tracxn data and company financials peg the deal value at 6x the revenue. Given the liquidity preferences investors would have in their term sheets, would the Biosense founders gain adequately from the acquisition after spending 12 years in building a company?

[[^message]]

Result

[[/message]] [[#message]]

[[message]]

[[/message]]